Skip to main content

#153234

Anti-CD55 [BU97]

Cat. #153234

Anti-CD55 [BU97]

Cat. #: 153234

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 3-4 weeks

Target: CD97 ligand

Class: Monoclonal

Application: IHC

Reactivity: Human

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Margaret Goodall

Institute: University of Birmingham

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-CD55 [BU97]
  • Alternate name: Complement decay-accelerating factor; CD55; Decay accelerating factor; DAF
  • Research fields: Cancer;Cell biology;Immunology
  • Clone: BU97
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Strain: Balb/c
  • Reactivity: Human
  • Host: Mouse
  • Application: IHC
  • Description: Macrophages are a type of white blood cell which through a process called phagocytosis engulfs and digests cellular debris, foreign substances, microbes, cancer cells. They can be found in all tissues where they play a critical role in the innate immune system and also help initiate adaptive immunity through recruiting lymphocytes and other immune cells. Germinal centres are sites within secondary lymph nodes where mature B lymphocytes proliferate, differentiate and mutate their antibody genes, enabling switching of their class of antibody during the course of infection.
  • Isotype: IgG2b

Target Details

  • Target: CD97 ligand
  • Target background: Macrophages are a type of white blood cell which through a process called phagocytosis engulfs and digests cellular debris, foreign substances, microbes, cancer cells. They can be found in all tissues where they play a critical role in the innate immune system and also help initiate adaptive immunity through recruiting lymphocytes and other immune cells. Germinal centres are sites within secondary lymph nodes where mature B lymphocytes proliferate, differentiate and mutate their antibody genes, enabling switching of their class of antibody during the course of infection.

Applications

  • Application: IHC

Handling

  • Format: Liquid
  • Concentration: 0.9-1.1 mg/ml
  • Unit size: 100 ug
  • Storage buffer: PBS with 0.02% azide
  • Storage conditions: -15° C to -25° C
  • Shipping conditions: Dry ice

References

  • Leucocyte Typing VI, 1998, Kishimoto_T. Garland Publishing, NY.
  • Ling et al. 1998. Clin Exp Immunol. 113(3):360-6. PMID: 9737663.
  • Origin and properties of soluble CD21 (CR2) in human blood.
  • Buescher et al. 1991. Public Health Rep. 106(3):333-8. PMID: 1905057.
  • Problems in estimating the number of women in need of subsidized prenatal care.

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.